Cargando…

Cohort Profile: The Danish Testicular Cancer Late Treatment Effects Cohort (DaTeCa-LATE)

The cohort was set up in order to analyze late effects in long-term testicular cancer survivors (TCS) and to contribute to the design of future follow-up programs addressing and potentially preventing late effects. Data for this cross-sectional study were collected between January 1, 2014, and Decem...

Descripción completa

Detalles Bibliográficos
Autores principales: Kreiberg, Michael, Bandak, Mikkel, Lauritsen, Jakob, Skøtt, Julie Wang, Johansen, Nanna Borup, Agerbaek, Mads, Holm, Niels Vilstrup, Johansen, Christoffer, Daugaard, Gedske
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5826343/
https://www.ncbi.nlm.nih.gov/pubmed/29515973
http://dx.doi.org/10.3389/fonc.2018.00037
_version_ 1783302333613998080
author Kreiberg, Michael
Bandak, Mikkel
Lauritsen, Jakob
Skøtt, Julie Wang
Johansen, Nanna Borup
Agerbaek, Mads
Holm, Niels Vilstrup
Johansen, Christoffer
Daugaard, Gedske
author_facet Kreiberg, Michael
Bandak, Mikkel
Lauritsen, Jakob
Skøtt, Julie Wang
Johansen, Nanna Borup
Agerbaek, Mads
Holm, Niels Vilstrup
Johansen, Christoffer
Daugaard, Gedske
author_sort Kreiberg, Michael
collection PubMed
description The cohort was set up in order to analyze late effects in long-term testicular cancer survivors (TCS) and to contribute to the design of future follow-up programs addressing and potentially preventing late effects. Data for this cross-sectional study were collected between January 1, 2014, and December 31, 2016, among living Danish TCS and 60% agreed to participate in the cohort (N = 2,572). Mean time since testicular cancer (TC) diagnosis was 18 years (range 7–33) and mean age of participants was 53 years (range 25–95). Data consist of results of a questionnaire with patient reported outcomes which covers a broad range of items on late-effects. The study also included data obtained through linkages to Danish registries, a biobank, and clinical data from hospital files and pathology reports originating from the Danish Testicular Cancer Database (DaTeCa). The treatment during the observation period has been nearly the same for all stages of TC and is in agreement with today’s standard treatment, this allows for interesting analysis with a wide timespan. We have extensive data on non-responders and are able to validate our study findings. Data from a Danish reference population (N = 162,283) allow us to compare our findings with a Danish background population. The cohort can easily be extended to access more outcomes, or include new TCS. A limitation of the present study is the cross-sectional design and despite the large sample size, The Danish Testicular Cancer Late Treatment Effects Cohort (DaTeCa-LATE) lacks statistical power to study very rare late effects. Since it was voluntary to participate in the study we have some selection bias, for instance, we lack responders who were not in a paired relationship, but we would still argue that this cohort of TCSs is representative for TCSs in Denmark. COLLABORATION AND DATA ACCESS: Researches interested in collaboration with the DaTeCa-LATE study group please contact Professor Gedske Daugaard kirsten.gedske.daugaard@regionh.dk.
format Online
Article
Text
id pubmed-5826343
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-58263432018-03-07 Cohort Profile: The Danish Testicular Cancer Late Treatment Effects Cohort (DaTeCa-LATE) Kreiberg, Michael Bandak, Mikkel Lauritsen, Jakob Skøtt, Julie Wang Johansen, Nanna Borup Agerbaek, Mads Holm, Niels Vilstrup Johansen, Christoffer Daugaard, Gedske Front Oncol Oncology The cohort was set up in order to analyze late effects in long-term testicular cancer survivors (TCS) and to contribute to the design of future follow-up programs addressing and potentially preventing late effects. Data for this cross-sectional study were collected between January 1, 2014, and December 31, 2016, among living Danish TCS and 60% agreed to participate in the cohort (N = 2,572). Mean time since testicular cancer (TC) diagnosis was 18 years (range 7–33) and mean age of participants was 53 years (range 25–95). Data consist of results of a questionnaire with patient reported outcomes which covers a broad range of items on late-effects. The study also included data obtained through linkages to Danish registries, a biobank, and clinical data from hospital files and pathology reports originating from the Danish Testicular Cancer Database (DaTeCa). The treatment during the observation period has been nearly the same for all stages of TC and is in agreement with today’s standard treatment, this allows for interesting analysis with a wide timespan. We have extensive data on non-responders and are able to validate our study findings. Data from a Danish reference population (N = 162,283) allow us to compare our findings with a Danish background population. The cohort can easily be extended to access more outcomes, or include new TCS. A limitation of the present study is the cross-sectional design and despite the large sample size, The Danish Testicular Cancer Late Treatment Effects Cohort (DaTeCa-LATE) lacks statistical power to study very rare late effects. Since it was voluntary to participate in the study we have some selection bias, for instance, we lack responders who were not in a paired relationship, but we would still argue that this cohort of TCSs is representative for TCSs in Denmark. COLLABORATION AND DATA ACCESS: Researches interested in collaboration with the DaTeCa-LATE study group please contact Professor Gedske Daugaard kirsten.gedske.daugaard@regionh.dk. Frontiers Media S.A. 2018-02-21 /pmc/articles/PMC5826343/ /pubmed/29515973 http://dx.doi.org/10.3389/fonc.2018.00037 Text en Copyright © 2018 Kreiberg, Bandak, Lauritsen, Skøtt, Johansen, Agerbaek, Holm, Johansen and Daugaard. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Kreiberg, Michael
Bandak, Mikkel
Lauritsen, Jakob
Skøtt, Julie Wang
Johansen, Nanna Borup
Agerbaek, Mads
Holm, Niels Vilstrup
Johansen, Christoffer
Daugaard, Gedske
Cohort Profile: The Danish Testicular Cancer Late Treatment Effects Cohort (DaTeCa-LATE)
title Cohort Profile: The Danish Testicular Cancer Late Treatment Effects Cohort (DaTeCa-LATE)
title_full Cohort Profile: The Danish Testicular Cancer Late Treatment Effects Cohort (DaTeCa-LATE)
title_fullStr Cohort Profile: The Danish Testicular Cancer Late Treatment Effects Cohort (DaTeCa-LATE)
title_full_unstemmed Cohort Profile: The Danish Testicular Cancer Late Treatment Effects Cohort (DaTeCa-LATE)
title_short Cohort Profile: The Danish Testicular Cancer Late Treatment Effects Cohort (DaTeCa-LATE)
title_sort cohort profile: the danish testicular cancer late treatment effects cohort (dateca-late)
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5826343/
https://www.ncbi.nlm.nih.gov/pubmed/29515973
http://dx.doi.org/10.3389/fonc.2018.00037
work_keys_str_mv AT kreibergmichael cohortprofilethedanishtesticularcancerlatetreatmenteffectscohortdatecalate
AT bandakmikkel cohortprofilethedanishtesticularcancerlatetreatmenteffectscohortdatecalate
AT lauritsenjakob cohortprofilethedanishtesticularcancerlatetreatmenteffectscohortdatecalate
AT skøttjuliewang cohortprofilethedanishtesticularcancerlatetreatmenteffectscohortdatecalate
AT johansennannaborup cohortprofilethedanishtesticularcancerlatetreatmenteffectscohortdatecalate
AT agerbaekmads cohortprofilethedanishtesticularcancerlatetreatmenteffectscohortdatecalate
AT holmnielsvilstrup cohortprofilethedanishtesticularcancerlatetreatmenteffectscohortdatecalate
AT johansenchristoffer cohortprofilethedanishtesticularcancerlatetreatmenteffectscohortdatecalate
AT daugaardgedske cohortprofilethedanishtesticularcancerlatetreatmenteffectscohortdatecalate